Shuangyuan Wang
- Molecular Biology
- Spectroscopy top 5%
- Epidemiology
- Endocrinology, Diabetes and Metabolism top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers)Liver Disease Diagnosis and Treatment (16 papers)Metabolomics and Mass Spectrometry Studies (10 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Shuangyuan Wang
67 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 450
- Spectroscopy 293
- Epidemiology 214
- Endocrinology, Diabetes and Metabolism 207
- Cardiology and Cardiovascular Medicine 164
Countries citing papers authored by Shuangyuan Wang
This map shows the geographic impact of Shuangyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangyuan Wang more than expected).
Fields of papers citing papers by Shuangyuan Wang
This network shows the impact of papers produced by Shuangyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangyuan Wang. The network helps show where Shuangyuan Wang may publish in the future.
Co-authorship network of co-authors of Shuangyuan Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Shuangyuan Wang. A scholar is included among the top collaborators of Shuangyuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangyuan Wang. Shuangyuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 30 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 11 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 9 | |
| 13 | 3 | |
| 14 | 3 | |
| 15 | 7 | |
| 16 | 10 | |
| 17 | 17 | |
| 18 | 22 | |
| 19 | 102 | |
| 20 | 29 |
About Shuangyuan Wang
Shuangyuan Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Liver Disease Diagnosis and Treatment (16 papers) and Metabolomics and Mass Spectrometry Studies (10 papers). The work is most often cited by research in Spectroscopy (293 citations), Analytical Chemistry (121 citations) and Endocrinology, Diabetes and Metabolism (207 citations). Shuangyuan Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Guowang Xu, Xianzhe Shi, Jieli Lu, Weiqing Wang, Mian Li, Yufang Bi, Guang Ning, Tiange Wang, Min Xu and Zhiyun Zhao. Their work appears in journals such as Analytical Chemistry, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.